HR 1032
108th Congress
House
Health
Ambulatory care
Cancer
Chemotherapy
Congress
Congressional investigations
Congressional reporting requirements
Drug therapy
Drugs
Economics and Public Finance
Federal budgets
Hospital rates
Legislation
Medical fees
Medicare
Off-budget expenditures
Pharmacies
Prescription pricing
Social Welfare
Beneficiary Access to Care Act of 2003
Introduced: February 27, 2003
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 10, 2003
Referred to the Subcommittee on Health.
Feb 27, 2003
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 27, 2003
Introduced in House
Plain-English summary
Beneficiary Access to Care Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act with respect to the prospective payment system for hospital outpatient department services (OPD) to: (1) require the Secretary of Health and Human Services to treat as a separate group of covered OPD services any drug or biological that was treated as such a group as of December 31, 2002, and any drug or biological that has ceased to be eligible for transitional, pass-through payments by reason of the limited period of payment specified; and (2) add special rules for 2004 for the calculation of Medicare OPD fee schedule amounts, among other payment-related changes.
Directs the Comptroller General to study and report to Congress on pharmacy services used to provide cancer drug therapies in hospital outpatient setting.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4
Cosponsors
1